MedPro Safety Products Completes Testing of VACUETTE® PREMIUM Safety Needle

LEXINGTON, Ky.--(BUSINESS WIRE)--MedPro Safety Products, Inc. (OTCBB: MPSP.OB), a pioneer in the development and marketing of passive needlestick injury prevention technology, announced today it has completed preliminary testing and regulatory requirements for the VACUETTE® PREMIUM Safety Needle System Tube-Touch model, a single-patient, multiple sample blood collection safety needle system. The VACUETTE® product now meets FDA requirements, ISO requirements, customer and MedPro stipulated testing protocols, and safety and efficacy standards. MedPro offers products which comply with the Federal NeedleStick Safety and Prevention Act of 2000 in that they are fully passive, enabling the safety mechanisms to be automatically activated.

The Company announced in July 2008 that a premier international manufacturer and supplier of medical products signed an agreement for the exclusive rights to manufacture, market and distribute this safety needle system. MedPro and the manufacturer later extended the original agreement to incorporate all of the Company’s products in the phlebotomy market segment, which include a tube and skin activated model, both FDA 510(k) cleared, as well as its wing safety model. MedPro is developing other products for intravenous, clinical healthcare and pharmaceutical markets.

“This is a key milestone for MedPro. Our business model is to develop, design and begin product assembly, then partner our needle safety technology with a recognized market leader who will take over commercial high volume production and distribution,” said MedPro’s President and COO Walter Weller. “We are on track to deliver this product to our partner on time. We currently expect to record revenue from sales in the fourth quarter of 2009. The phlebotomy market is estimated to use approximately 700 million units in the United States and 1.5 billion units worldwide.”

According to Dr. Joel Swanson, of Pittsburgh, “Roughly 83 percent of the nation’s acute-care facilities use some form of safety blood collection device, such as VACUETTE®. The system is unique in that it is “fully passive.” The operator cannot draw blood without having engaged the safety system. I am not aware of any other superior blood collection devices being developed in the phlebotomy market.”

About MedPro Safety Products, Inc.

Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. (OTCBB: MPSP.OB) has developed and acquired a portfolio of medical safety products incorporating proprietary needlestick prevention functionalities. For additional information, please refer to the ‘Investor Relations’ link on the Company’s website (http://www.medprosafety.com).

Safe Harbor Statement

This release includes forward-looking statements based upon current expectations of the management of MedPro Safety Products, Inc. that involve risks and uncertainties, such as plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward- looking statements as a result of a number of factors, including our ability to identify and acquire medical safety device safety technologies with product development potential; our ability to successfully develop and bring products to market, including obtaining regulatory approvals; our ability to successfully increase sales of our products; our ability to obtain additional financing on satisfactory terms; our ability to attract and retain qualified employees; and governmental regulation associated with the medical safety products industry. Words such as "anticipate," "estimate," "plan," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," and similar expressions are used to identify forward-looking statements. We refer you to the more detailed discussion of risks and uncertainties under "Risk Factors" in our Annual Report on Form 10-K and our other reports on file with the Securities and Exchange Commission.

Investor:
EVC Group
Doug Sherk/Stacey Fisher/Mike Pollock
415-896-6820
or
Media:
EVC Group
Steve DiMattia, 646-201-5445